Archive for February 2024

Dilon Technologies Announces Beginning Enrollment in its Pivotal Trial of the Next Generation MarginProbeTM 2 Used in Real-Time Margin Assessment. NEWPORT NEWS, VA, Feb 5, 2024 (PRNewswire) –Dilon Technologies Inc. announced today the enrollment of its first patient in the Prospective, Single-Arm, Multi-Center Pivotal Trial for its next generation MarginProbe 2 product used in real-time…